京新药业(002020.SZ)：公司的盐酸卡利拉嗪已申报待批准

Core Viewpoint - Jingxin Pharmaceutical (002020.SZ) has submitted its application for the approval of its drug, Calcitonin Salts, which is currently pending approval [1] Company Summary - Jingxin Pharmaceutical is actively pursuing the approval of its hydrochloride formulation of Calcitonin Salts, indicating a step forward in its product pipeline [1]